Bellecapital International Ltd. Moderna, Inc. Transaction History

Bellecapital International Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$118.38 - $210.04 $182,305 - $323,461	1,540 New	1,540 $276,000
Q1 2022 May 03, 2022	BUY	$126.46 - $235.05 $48,687 - $90,494	385 Added 5.25%	7,716 $1.33 Million
Q4 2021 Jan 20, 2022	SELL	$225.82 - $368.51 $351,827 - $574,138	-1,558 Reduced 17.53%	7,331 $1.86 Million
Q3 2021 Oct 21, 2021	BUY	$221.9 - $484.47 $33,285 - $72,670	150 Added 1.72%	8,889 $3.42 Million
Q2 2021 Jul 28, 2021	BUY	$129.91 - $234.98 $211,623 - $382,782	1,629 Added 22.91%	8,739 $2.05 Million
Q1 2021 Apr 13, 2021	BUY	$109.18 - $185.98 $776,269 - $1.32 Million	7,110 New	7,110 $931,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Bellecapital International Ltd., based on Form 13F filings with the SEC.

Stay updated on Bellecapital International Ltd. with notifications on news.